Start-Up Spotlight: Resonant Link Plans To Electrify Device Industry With Efficient Wireless Charging Technology
The company is commercializing technology developed at Dartmouth and Stanford universities, hoping that its technology will reduce the size and complication rates of implantable devices.
You may also be interested in...
As Omicron further destabilizes the medtech space, potentially mirroring the spring of 2020, some executives shared with Medtech Insight their views on what will hopefully be a bumper year for the sector.
The company says popular products like iPhones, iPads, AirPods and MacBook laptops contain magnets that could adversely affect the function of implantables, including pacemakers and defibrillators.
Although near-term challenges have slowed growth in the market for left ventricular assist devices (LVADs), companies are developing new, less invasive VADs with improved pump designs to further improve patient outcomes and allow for a wider application of the therapy in treating heart failure. These next-generation VADs are fueling long-term optimism in the market for mechanical circulatory support, which remains one of the more attractive opportunities in the cardiovascular space.